Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
J Manag Care Spec Pharm. 2021 Aug;27(8):1046-1055. doi: 10.18553/jmcp.2021.27.8.1046.
J Manag Care Spec Pharm. 2021.
PMID: 34337994